Table of Contents
<< Previous Issue | Aug 2015 (Vol: 2015, Issue: 8) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Novartis Bolts on Spinifex to Bolster its Neuroscience Franchise
-
Celgene Looks to Build Critical Mass in Inflammation and Immunology via US$7.2 B Receptos Acquisition
-
Teva Drops Mylan Bid with US$40.5 B Acquisition of Allergan Generics
- Section: Opinion & Analysis
-
IMS PharmaDeals Half-Year Review of 2015